Pdtb-27. precision medicine in pediatric neuro-oncology
CONCLUSION:We strongly encourage patients to enroll in our precision medicine pathway. The WES platform capture reads for over 20,000 genes and offers a unique data set that may shed light on both known cancer relevant somatic alterations but also functional relevance for less known mutations on a case-specific basis.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Rajappa, P., Pisapia, D. Tags: PEDIATRIC TUMORS - PRECLINICAL STUDIES (NON-IMMUNOLOGICAL) Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Genetics | Neurology | Pediatrics | Study